Neogenomics Inc
NEO10.420USD
+0.020+0.19%
Handelsschluss 11/11, 16:00（ET）Kurse um 15 Minuten verzögert
1.34BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Neogenomics Inc Unternehmen
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.
Neogenomics Inc Informationen
BörsenkürzelNEO
Name des UnternehmensNeogenomics Inc
IPO-datumDec 10, 2012
CEOMr. Antony P. Zook
Anzahl der mitarbeiter2200
WertpapierartOrdinary Share
GeschäftsjahresendeDec 10
Addresse9490 Neogenomics Way
StadtFORT MYERS
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl33912
Telefon12397680600
Websitehttps://neogenomics.com/
BörsenkürzelNEO
IPO-datumDec 10, 2012
CEOMr. Antony P. Zook
Führungskräfte von Neogenomics Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Gregory Aunan
Mr. Gregory Aunan
Chief Accounting Officer
Chief Accounting Officer
--
--
Ms. Alicia Olivo
Ms. Alicia Olivo
Executive Vice President, General Counsel & Business Development
Executive Vice President, General Counsel & Business Development
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
186.66K
+12.00%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
108.28K
+19.26%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
52.34K
+30.57%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
28.10K
+77.33%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
7.16K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
131.16M
72.33%
Clinical Services-Commercial Insurance
28.77M
15.86%
Clinical Services-Medicare and Medicaid
21.39M
11.79%
Clinical Services-Self-Pay
20.00K
0.01%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Clinical Services-Client direct billing
131.16M
72.33%
Clinical Services-Commercial Insurance
28.77M
15.86%
Clinical Services-Medicare and Medicaid
21.39M
11.79%
Clinical Services-Self-Pay
20.00K
0.01%
Aktionärsstatistik
Aktualisiert: Fri, Oct 31
Aktualisiert: Fri, Oct 31
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.73%
The Vanguard Group, Inc.
10.72%
Greenhouse Funds LLLP
5.74%
First Light Asset Management, LLC
5.29%
State Street Investment Management (US)
3.95%
Andere
60.56%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.73%
The Vanguard Group, Inc.
10.72%
Greenhouse Funds LLLP
5.74%
First Light Asset Management, LLC
5.29%
State Street Investment Management (US)
3.95%
Andere
60.56%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.75%
Investment Advisor/Hedge Fund
30.92%
Hedge Fund
13.93%
Research Firm
2.37%
Individual Investor
1.29%
Pension Fund
1.20%
Bank and Trust
0.59%
Sovereign Wealth Fund
0.09%
Family Office
0.05%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
568
127.88M
98.83%
-9.78M
2025Q2
571
126.82M
98.17%
-12.95M
2025Q1
596
131.44M
102.13%
-4.71M
2024Q4
585
127.59M
99.32%
-7.82M
2024Q3
589
129.38M
100.96%
-8.76M
2024Q2
597
131.21M
102.74%
-9.36M
2024Q1
633
132.83M
104.04%
-13.13M
2023Q4
672
130.90M
102.70%
-12.18M
2023Q3
691
124.98M
98.00%
-16.78M
2023Q2
691
121.76M
95.45%
-23.63M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
17.77M
13.76%
-516.86K
-2.83%
Jun 30, 2025
The Vanguard Group, Inc.
14.10M
10.92%
-126.36K
-0.89%
Jun 30, 2025
Greenhouse Funds LLLP
7.43M
5.75%
+2.72M
+57.83%
Jun 30, 2025
First Light Asset Management, LLC
6.85M
5.3%
+803.61K
+13.30%
Jun 30, 2025
State Street Investment Management (US)
5.11M
3.96%
+21.77K
+0.43%
Jun 30, 2025
Macquarie Investment Management
4.81M
3.72%
+130.73K
+2.80%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.29M
3.32%
+448.53K
+11.66%
Jun 30, 2025
Schroder Investment Management North America Inc.
3.72M
2.88%
-587.33K
-13.63%
Jun 30, 2025
American Century Investment Management, Inc.
3.52M
2.72%
+197.88K
+5.96%
Jun 30, 2025
Millennium Management LLC
3.32M
2.57%
-3.40M
-50.63%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
SPDR S&P Health Care Services ETF
1.75%
Invesco S&P SmallCap Health Care ETF
0.63%
WisdomTree BioRevolution Fund
0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.4%
Inspire Small/Mid Cap ESG ETF
0.2%
iShares U.S. Healthcare Providers ETF
0.16%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.09%
Nuveen ESG Small-Cap ETF
0.09%
iShares ESG Select Screened S&P Small-Cap ETF
0.08%
SPDR S&P 600 Small Cap Value ETF
0.08%
Mehr Anzeigen
SPDR S&P Health Care Services ETF
Anteil1.75%
Invesco S&P SmallCap Health Care ETF
Anteil0.63%
WisdomTree BioRevolution Fund
Anteil0.58%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil0.4%
Inspire Small/Mid Cap ESG ETF
Anteil0.2%
iShares U.S. Healthcare Providers ETF
Anteil0.16%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Anteil0.09%
Nuveen ESG Small-Cap ETF
Anteil0.09%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.08%
SPDR S&P 600 Small Cap Value ETF
Anteil0.08%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
